Amneal Pharmaceuticals announced a 10-year license and supply agreement for Levothyroxine sodium tablets with Jerome Stevens Pharmaceuticals, Inc. (JSP), a New York-based pharmaceutical manufacturer of prescription tablet and capsule formulations. The agreement is effective March 22, 2019. “Levothyroxine is one of the most compelling generic product markets in the United States today,” said Rob Stewart, president and chief executive officer of Amneal. “With more than 120 mil...